Atlas Trials

Evaluation of Ganovo (Danoprevir ) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection

Clinical trial NCT04291729 · COMPLETED

Trial details

NCT number
NCT04291729
Sponsor
The Ninth Hospital of Nanchang
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
COVID-19
Start date
2020-02-17
Primary completion
2020-03-19
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.